Coronavirus Update: 'Positive News' Imminent From Oxford and AstraZeneca Vaccine
Plus: Favipiravir Price Cut And New Approval In India
More news from across the sector, including Novartis's non-profit pledge on medicines and Zydus Cadila commencing Phase I vaccine trial.
